These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27531882)

  • 21. Transoral robotic versus open surgical approaches to oropharyngeal squamous cell carcinoma by human papillomavirus status.
    Ford SE; Brandwein-Gensler M; Carroll WR; Rosenthal EL; Magnuson JS
    Otolaryngol Head Neck Surg; 2014 Oct; 151(4):606-11. PubMed ID: 25049265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Surgery in the Management of Recurrent Oropharyngeal Cancer.
    Gross ND; Hanna EY
    Recent Results Cancer Res; 2017; 206():197-205. PubMed ID: 27699540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment Outcomes for T4 Oropharyngeal Squamous Cell Carcinoma.
    Zenga J; Wilson M; Adkins DR; Gay HA; Haughey BH; Kallogjeri D; Michel LS; Paniello RC; Rich JT; Thorstad WL; Nussenbaum B
    JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1118-27. PubMed ID: 25902372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of gastrostomy tube dependence in surgically managed oropharyngeal squamous cell carcinoma.
    Varma VR; Eskander A; Kang SY; Kumar B; Brown NV; Zhao S; Brock G; Agrawal A; Carrau RL; Old MO; Ozer E; Rocco JW; Schuller DE; Dziegielewski PT; Cipolla MJ; Teknos TN
    Laryngoscope; 2019 Feb; 129(2):415-421. PubMed ID: 30194767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
    Haughey BH; Sinha P
    Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of overall survival in human papillomavirus-associated oropharyngeal cancer using the National Cancer Data Base.
    Amini A; Jasem J; Jones BL; Robin TP; McDermott JD; Bhatia S; Raben D; Jimeno A; Bowles DW; Karam SD
    Oral Oncol; 2016 May; 56():1-7. PubMed ID: 27086480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival for HPV-positive oropharyngeal squamous cell carcinoma with surgical versus non-surgical treatment approach: A systematic review and meta-analysis.
    Sinha P; Karadaghy OA; Doering MM; Tuuli MG; Jackson RS; Haughey BH
    Oral Oncol; 2018 Nov; 86():121-131. PubMed ID: 30409292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of Transoral Robotic Surgery in the Management of HPV Negative Oropharyngeal Squamous Cell Carcinoma.
    Sload R; Silver N; Jawad BA; Gross ND
    Curr Oncol Rep; 2016 Sep; 18(9):53. PubMed ID: 27469262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of HPV status with survival after surgical salvage of oropharyngeal cancers.
    Patel TR; Lee S; Tajudeen BA; Stenson K; Bhayani M; Al-Khudari S
    Am J Otolaryngol; 2022; 43(4):103491. PubMed ID: 35567838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival outcomes following salvage surgery for oropharyngeal squamous cell carcinoma: systematic review.
    Kao SS; Ooi EH
    J Laryngol Otol; 2018 Apr; 132(4):299-313. PubMed ID: 28502256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Phase 2 Trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification (AVOID): Omission of the Resected Primary Tumor Bed After Transoral Robotic Surgery for Human Papilloma Virus-Related Squamous Cell Carcinoma of the Oropharynx.
    Swisher-McClure S; Lukens JN; Aggarwal C; Ahn P; Basu D; Bauml JM; Brody R; Chalian A; Cohen RB; Fotouhi-Ghiam A; Geiger G; Gershowitz J; Livolsi V; Mitra N; Montone K; Newman J; Ojerholm E; O'Malley B; Rajasekaran K; Tan E; Weinstein G; Lin A
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):725-732. PubMed ID: 31785337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of pretreatment body mass index and survival in human papillomavirus positive oropharyngeal squamous cell carcinoma.
    Albergotti WG; Davis KS; Abberbock S; Bauman JE; Ohr J; Clump DA; Heron DE; Duvvuri U; Kim S; Johnson JT; Ferris RL
    Oral Oncol; 2016 Sep; 60():55-60. PubMed ID: 27531873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human papillomavirus type 16 oropharyngeal cancers in lymph nodes as a marker of metastases.
    Mirghani H; Moreau F; Lefèvre M; Tam C; Périé S; Soussan P; St Guily JL
    Arch Otolaryngol Head Neck Surg; 2011 Sep; 137(9):910-4. PubMed ID: 21930979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era.
    Keane FK; Chen YH; Neville BA; Tishler RB; Schoenfeld JD; Catalano PJ; Margalit DN
    Cancer; 2015 Aug; 121(15):2594-602. PubMed ID: 25873094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer.
    Iyer NG; Dogan S; Palmer F; Rahmati R; Nixon IJ; Lee N; Patel SG; Shah JP; Ganly I
    Ann Surg Oncol; 2015 Dec; 22(13):4411-21. PubMed ID: 25801358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disease-free survival after salvage therapy for recurrent oropharyngeal squamous cell carcinoma.
    Joseph AW; Guo T; Hur K; Xie Y; Yin L; Califano JA; Ha PK; Quon H; Richmon JD; Eisele DW; Agrawal N; Fakhry C
    Head Neck; 2016 Apr; 38 Suppl 1():E1501-9. PubMed ID: 26558328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relapse Rates With Surgery Alone in Human Papillomavirus-Related Intermediate- and High-Risk Group Oropharynx Squamous Cell Cancer: A Multi-Institutional Review.
    Routman DM; Funk RK; Tangsriwong K; Lin A; Keeney MG; García JJ; Zarka MA; Lewis JT; Stoddard DG; Moore EJ; Day CN; Zhai Q; Price KA; Lukens JN; Swisher-McClure S; Weinstein GS; O'Malley BW; Foote RL; Ma DJ
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):938-946. PubMed ID: 28847412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymph Node Ratio in HPV-Associated Oropharyngeal Cancer: Identification of a Prognostic Threshold.
    Bu DD; Ferrandino R; Robinson EM; Liu S; Miles BA; Teng MS; Yao M; Genden EM; Chai RL
    Laryngoscope; 2021 Jan; 131(1):E184-E189. PubMed ID: 32348558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No evidence for active human papillomavirus (HPV) in fields surrounding HPV-positive oropharyngeal tumors.
    Rietbergen MM; Braakhuis BJ; Moukhtari N; Bloemena E; Brink A; Sie D; Ylstra B; Baatenburg de Jong RJ; Snijders PJ; Brakenhoff RH; Leemans CR
    J Oral Pathol Med; 2014 Feb; 43(2):137-42. PubMed ID: 24118314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of failure in high-metastatic node number human papillomavirus-positive oropharyngeal carcinoma.
    Lee NCJ; Kelly JR; Park HS; An Y; Judson BL; Burtness BA; Husain ZA
    Oral Oncol; 2018 Oct; 85():35-39. PubMed ID: 30220317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.